DOCSLIB.ORG

Securities Margin Shares Pledged List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Securities Margin Shares Pledged List Serial Stock Code Stock Name Pledged Ratio 1 0001 CKH HOLDINGS 60% 2 0002 CLP HOLDINGS 60% 3 0003 CHING GAS 60% 4 0004 WHARF HOLDINGS 60% 5 0005 HSBC HOLDINGS 70% 6 0006 POWER ASSETS 60% 7 0008 PCCW 40% 8 0010 HANG LUNG GROUP 40% 9 0011 HANG SENG BANK 60% 10 0012 HENDERSON LAND 60% 11 0014 HYSAN DEV 40% 12 0016 SHK PPT 60% 13 0017 NEW WORLD DEV 60% 14 0019 SWIRE PACIFIC A 60% 15 0020 WHEELOCK 50% 16 0023 BANK OF E ASIA 60% 17 0027 GALAXY ENT 60% 18 0041 GREAT EAGLE H 30% 19 0066 MTR CORP 60% 20 0069 SHANGRI-LA ASIA 40% 21 0081 CH OVS G OCEANS 30% 22 0083 SINO LAND 60% 23 0087 SWIRE PACIFIC B 20% 24 0101 HANG LUNG PPT 60% 25 0119 POLY PROPERTY 30% 26 0123 YUEXIU PROPERTY 40% 27 0135 KUNLUN ENERGY 50% 28 0142 FIRST PACIFIC 30% 29 0144 CHINA MER PORT 60% 30 0148 KINGBOARD HLDG 40% 31 0151 WANT WANT CHINA 50% 32 0152 SHENZHEN INT'L 30% 33 0165 CHINA EB LTD 40% 34 0168 TSINGTAO BREW 40% 35 0173 K WAH INT'L 30% 36 0175 GEELY AUTO 60% 37 0177 JIANGSU EXPRESS 30% 38 0178 SA SA INT'L 30% 39 0179 JOHNSON ELEC H 30% 1/7 Serial Stock Code Stock Name Pledged Ratio 40 0200 MELCO INT'L DEV 30% 41 0215 HUTCHTEL HK 20% 42 0220 U-PRESID CHINA 40% 43 0242 SHUN TAK HOLD 30% 44 0257 CHINA EB INT'L 40% 45 0267 CITIC 60% 46 0268 KINGDEE INT'L 20% 47 0270 GUANGDONG INV 40% 48 0272 SHUI ON LAND 30% 49 0285 BYD ELECTRONIC 30% 50 0288 WH GROUP 60% 51 0291 CHINA RES BEER 40% 52 0293 CATHAY PAC AIR 50% 53 0303 VTECH HOLDINGS 30% 54 0308 CHINA TRAVEL HK 30% 55 0315 SMARTONE TELE 20% 56 0322 TINGYI 50% 57 0323 MAANSHAN IRON 20% 58 0336 HUABAO INT'L 30% 59 0338 SHANGHAI PECHEM 30% 60 0341 CAFÉ DE CORAL H 20% 61 0347 ANGANG STEEL 30% 62 0354 CHINASOFT INT'L 20% 63 0358 JIANGXI COPPER 40% 64 0363 SHANGHAI IND H 40% 65 0371 BJEMT WATER 40% 66 0384 CHINA GAS HOLD 40% 67 0386 SINOPEC CORP 60% 68 0388 HKEX 60% 69 0390 CHINA RAILWAY 40% 70 0392 BEJING ENT 40% 71 0405 YUEXIU REIT 40% 72 0410 SOHO CHINA SOHO 40% 73 0425 MINTH GROUP 30% 74 0440 DAH SING 30% 75 0489 DONGFENG GROUP 40% 76 0494 LI & FUNG 40% 77 0522 ASM PACIFIC ASM 40% 78 0525 GUANGSHEN RAIL 30% 79 0548 SHENZHENEXPRESS 30% 80 0551 YUE YUEN IND 40% 81 0552 CHINACOMSERVICE 40% 82 0570 TRAD CHI MED 20% 83 0576 ZHEJIANGEXPRESS 30% 84 0586 CONCH VENTURE 30% 2/7 Serial Stock Code Stock Name Pledged Ratio 85 0590 LUK FOOK HOLD 30% 86 0604 SHENZHEN INVEST 30% 87 0606 CHINA AGRI 40% 88 0636 KERRY LOG NET 30% 89 0656 FOSUN INT'L 40% 90 0658 C TRANSMISSION 30% 91 0659 NWS HOLDINGS 40% 92 0665 HAITONG INT'L 20% 93 0669 TECHTRONIC IND 50% 94 0670 CHINA EAST AIR 30% 95 0683 KERRY PPT 40% 96 0688 CHINA OVERSEAS 60% 97 0694 BEJING AIRPORT 30% 98 0696 TRAVELSKY TECH 20% 99 0699 CAR INC 30% 100 0700 TENCENT 60% 101 0709 GIORDANO INT'L 20% 102 0728 CHINA TELECOM 50% 103 0751 SKYWORTH GROUP 40% 104 0753 AIR CHINA 40% 105 0762 CHINA UNICOM 60% 106 0763 ZTE 30% 107 0772 CHINA LIT 30% 108 0778 FORTUNE REIT 40% 109 0788 CHINA TOWER 30% 110 0799 IGG 20% 111 0813 SHIMAO PROPERTY 40% 112 0816 HUADIAN FUXIN 20% 113 0817 CHINA JINMAO 40% 114 0823 LINK REIT 60% 115 0836 CHINA RES POWER 60% 116 0857 PETROCHINA 70% 117 0867 CMS 20% 118 0868 XINYI GLASS 40% 119 0874 BAIYUNSHAN PH 30% 120 0880 SJM HOLDINGS 40% 121 0881 中升控股 40% 122 0883 ZHONGSHENG HLDG 60% 123 0884 CIFI HOLD GP 20% 124 0902 HUANENG POWER 40% 125 0914 CONCH CEMENT 40% 126 0916 CHINA LONGYUAN 40% 127 0934 SINOPEC KANTONS 30% 128 0939 CCB 70% 129 0941 CHINA MOBILE 70% 3/7 Serial Stock Code Stock Name Pledged Ratio 130 0958 HN RENEWABLES 30% 131 0960 LONGFOR GROUP 40% 132 0966 CHINA TAIPING 40% 133 0968 XINYI SOLAR 30% 134 0973 L'Occitane 30% 135 0981 SMIC 40% 136 0991 DATANG POWER 40% 137 0992 LENOVO GROUP 50% 138 0998 CITIC BANK 50% 139 1038 CKI HOLDINGS 60% 140 1044 HENGAN INT'L 60% 141 1052 YUEXIU TRANSPORT 30% 142 1055 CHINA SOUTH AIR 30% 143 1066 WEIGAO GROUP 40% 144 1070 TCL ELECTRONICS 20% 145 1071 HUADIAN POWER 30% 146 1083 TOWNGAS CHINA 40% 147 1088 CHINA SHENHUA 60% 148 1093 CSPC PHARMA 50% 149 1099 SINOPHARM 40% 150 1109 CHINA RES LAND 50% 151 1112 H & H INT'L HLDG 30% 152 1113 CK ASSET 60% 153 1114 BRILLIANCE CHI 40% 154 1128 WYMN MACAU 40% 155 1133 HARBIN ELECTRIC 30% 156 1138 COSCO SHIP ENGY 30% 157 1157 ZOOMLION 20% 158 1169 HAIER ELEC 40% 159 1171 YANZHOU COAL 40% 160 1177 SINO BIOPHARM 50% 161 1186 CHINA RAIL CONS 40% 162 1193 CHINA RES GAS 40% 163 1199 COSCO SHIP PORT 40% 164 1208 MMG 20% 165 1211 BYD COMPANY 40% 166 1288 ABC 60% 167 1299 AIA 70% 168 1313 CHINARES CEMENT 40% 169 1316 NEXTEER 30% 170 1333 CHINA ZHONGWANG 30% 171 1336 NCI 40% 172 1339 PICC GROUP 40% 173 1347 HUA HONG SEMI 30% 174 1359 CHINA CINDA 40% 4/7 Serial Stock Code Stock Name Pledged Ratio 175 1382 PACIFIC TEXTILES 20% 176 1398 ICBC 70% 177 1458 ZHOU HEI YA 20% 178 1508 CHINA RE 40% 179 1513 LIVZON PHARMA 20% 180 1515 CR MEDICAL 20% 181 1530 3SBIO 30% 182 1558 HEC PHARM 20% 183 1658 PSBC 40% 184 1666 TONG REN TANG 30% 185 1668 CHINASOUTHCITY 30% 186 1680 MACAU LEGEND 20% 187 1728 ZHENGTONGAUTO 30% 188 1766 CRRC 40% 189 1776 GF SEC 30% 190 1788 GUOTAI JUNAN I 30% 191 1800 CHINA COMM CONS 40% 192 1810 XIAOMI-W 40% 193 1813 KWG GROUP 30% 194 1816 CGN POWER 30% 195 1818 ZHAOJIN MINING 30% 196 1833 PA GOODDOCTOR 30% 197 1882 HAITAN INT'L 20% 198 1883 CITIC TELECOM 20% 199 1888 KB LAMINATES 30% 200 1898 CHINA COAL 40% 201 1910 SAMONITE 40% 202 1918 SUNAC 30% 203 1919 COSCO SHIP HOLD 40% 204 1928 SANDS CHINA LTD 50% 205 1929 CHOW TAI FOOK 50% 206 1958 BAIC MOTOR 30% 207 1972 SWIRE PROPERTIES 50% 208 1988 MINSHENG BANK 50% 209 1997 WHARF REIC 50% 210 1999 MAN WAH HLDGS 30% 211 2007 COUNTRY GARDEN 50% 212 2009 BBMG 30% 213 2018 AAC TECH 50% 214 2020 ANTA SPORTS 40% 215 2039 CIMC 20% 216 2128 CHINA LESSO 30% 217 2186 LUYE PHARMA 20% 218 2196 FOSUN PHARMA 30% 219 2202 CHINA VANKE 40% 5/7 Serial Stock Code Stock Name Pledged Ratio 220 2208 GOLDWIND 30% 221 2238 GAC GROUP 40% 222 2269 WUXI BIO 30% 223 2282 MGM CHINA 40% 224 2313 SHENZHOU INT'L 50% 225 2314 LEE & MAN PAPER 40% 226 2318 PING AN 70% 227 2319 MENGNIU DAIRY 50% 228 2328 PICC P & C 40% 229 2331 LI NING 20% 230 2333 GREATWALL MOTOR 40% 231 2338 WEICHAI POWER 40% 232 2343 PACIFIC BASIN 20% 233 2357 AVICHINA 30% 234 2380 CHINA POWER 40% 235 2382 SUNNY OPTICAL 50% 236 2386 SINOPEC SEG 30% 237 2388 BOC HONG KONG 60% 238 2588 BOC AVIATION 20% 239 2600 CHALCO 30% 240 2601 CPIC 50% 241 2607 SH PHARMA 30% 242 2611 GTJA 30% 243 2628 CHINA LIFE 60% 244 2638 HKELECTRIC-SS 40% 245 2688 ENN ENERGY 50% 246 2689 ND PAPER 30% 247 2727 SH ELECTRIC 40% 248 2777 R & F PROPERTIES 30% 249 2778 CHAMPION REIT 40% 250 2799 CHINA HUARONG 30% 251 2800 TRACKER FUND 70% 252 2822 CSOP A50 ETF 40% 253 2823 ISHARES A50 60% 254 2828 HSCEI ETF 60% 255 2866 COSCO SHIP DEV 30% 256 2883 CHINA OILFIELD 40% 257 2888 STANCHART 50% 258 2899 ZIJIN MINING 40% 259 3188 CAM CSI300 40% 260 3311 CHINA STATE CON 50% 261 3320 CHINARES PHARMA 30% 262 3323 CNBM 40% 263 3328 BANKCOMM 60% 264 3333 EVERGRANDE 40% 6/7 Serial Stock Code Stock Name Pledged Ratio 265 3339 LONKING 30% 266 3360 FE HORIZON 20% 267 3377 SINO-OCEAN GP 40% 268 3383 AGILE GROUP 40% 269 3396 LEGEND HOLDING 30% 270 3606 FUYAO GLASS 20% 271 3618 CQRC BANK 30% 272 3799 DALI FOODS 30% 273 3800 GCL-POLY ENERGY 30% 274 3808 SINOTRUK 30% 275 3888 KINGSOFT 40% 276 3898 CRRC TIMES ELEC 30% 277 3899 CIMC ENRIC 40% 278 3900 GREENTOWN CHINA 30% 279 3908 CICC 30% 280 3933 UNITED LAB 20% 281 3968 CM BANK 50% 282 3969 CHINA CRSC 30% 283 3983 CHINA BLUECHEM 20% 284 3988 BANK OF CHINA 70% 285 3993 CMOC 20% 286 6030 CITIC SEC 40% 287 6060 ZA ONLINE 20% 288 6099 CMSC 20% 289 6808 SUNART RETAIL 40% 290 6818 CEB BANK 30% 291 6823 HKT-SS 40% 292 6837 HAITONG SEC 40% 293 6881 CGS 30% 294 6886 HTSC 30% Effective Date : Sept 16, 2019 7/7.
Recommended publications
  • SUNAC CHINA HOLDINGS LIMITED 融創中國控股有限公司 (Incorporated in the Cayman Islands with Limited Liability) (Stock Code: 01918)

    SUNAC CHINA HOLDINGS LIMITED 融創中國控股有限公司 (Incorporated in the Cayman Islands with Limited Liability) (Stock Code: 01918)

    THIS CIRCULAR IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt about any aspect of this circular or as to the action to be taken, you should consult your licensed securities dealer or registered institution in securities, bank manager, solicitor, professional accountant or other professional advisers. If you have sold or transferred all your shares in Sunac China Holdings Limited, you should at once hand this circular together with the enclosed form of proxy to the purchaser(s) or transferee(s) or to the bank, licensed securities dealer or registered institution in securities or other agent through whom the sale or transfer was effected for transmission to the purchaser(s) or transferee(s). Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this circular, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this circular. This circular appears for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities. SUNAC CHINA HOLDINGS LIMITED 融創中國控股有限公司 (incorporated in the Cayman Islands with limited liability) (Stock Code: 01918) (1) CONNECTED TRANSACTION — PROPOSED SHARE ISSUANCE UNDER SPECIFIC MANDATE AND (2) APPLICATION FOR WHITEWASH WAIVER Independent Financial Adviser to the Independent Board Committee and the Independent Shareholders Capitalised terms used on this cover shall have the same meanings as those defined in the section headed “Definition” in this circular, unless the context requires otherwise.
  • Three Red Lines” Policy

    Three Red Lines” Policy

    Real Estate Developers with High Leverage to See Inventory Quality Tested Under Broader “Three Red Lines” Policy October 28, 2020 In our view, the widening of regulations aimed at controlling real estate developers’ interest- ANALYSTS bearing debt would further reduce the industry’s overall credit risk in the long term. However, the nearer term may see less headroom for highly leveraged developers to finance in the capital Xiaoliang Liu, CFA market, pushing them to sell off inventory to ease liquidity pressure. Beijing +86-10-6516-6040 The People’s Bank of China said in September that measures aimed at monitoring the funding [email protected] and financial management of key real estate developers will steadily be expanded. Media reports suggest that the new regulations would see a cap of 15% on annual growth of interest-bearing Jin Wang debt for all property developers. Developers will be assessed against three indicators, which are Beijing called “red lines”: whether asset liability ratios (excluding advance) exceeded 70%; whether net +86-10-6516-6034 gearing ratio exceeded 100%; whether cash to short-term debt ratios went below 1.0. Developers [email protected] which breached all three red lines won’t be allowed to increase their debt. If only one or two of the red lines are breached, such developers would have their interest-bearing debt growth capped at 5% and 10% respectively. The first half of the year saw debt grow rapidly among developers. In a sample of 87 real estate developers that we are monitoring, more than 40% saw their interest-bearing debt grow at a faster rate than 15% year over year as of the end of June (see the chart below).
  • Global Offering

    Global Offering

    (Incorporated in the Cayman Islands with limited liability) Stock Code: Global Offering Joint Sponsors, Joint Global Coordinators, Joint Bookrunners and Joint Leadad ManagersManagers (in alphabetical order) Other Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager Other Joint Bookrunners and Joint Lead Managers (in alphabetical order) Project A_PPTUS cover(Eng) Cover size: 210 x 280mm / Open size: 445.3 x 280mm / Spine width: 25.3mm IMPORTANT If you are in any doubt about any of the contents of this prospectus, you should obtain independent professional advice. (Incorporated in the Cayman Islands with limited liability) GLOBAL OFFERING Number of Offer Shares under : 550,000,000 Shares (subject to the Over- the Global Offering allotment Option) Number of Hong Kong Offer Shares : 27,500,000 Shares (subject to reallocation) Number of International Offer Shares : 522,500,000 Shares (including 55,000,000 Reserved Shares under the Preferential Offering) (subject to reallocation and the Over-allotment Option) Maximum Offer Price : HK$22.30 per Share plus brokerage of 1.0%, SFC transaction levy of 0.0027% and the Hong Kong Stock Exchange trading fee of 0.005% (payable in full on application, subject to refund) Nominal value : US$0.00001 per Share Stock code : 1209 Joint Sponsors, Joint Global Coordinators, Joint Bookrunners and Joint Lead Managers (in alphabetical order) Other Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager Other Joint Bookrunners and Joint Lead Managers (in alphabetical order) Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus.
  • Annual Report

    Annual Report

    2020 (Incorporated in Hong Kong with limited liability) (Stock Code : 00656) Annual Report Profit Attributable to Owners of the Parent RMB 8,017.9 million Innovation & Win The year 2020 might be the most challenging year for Fosun, yet it was also the best year. After the pandemic, we continue with the “wartime mechanism” and maintain the fighting spirit that we have developed during the global combat against COVID-19. This has resulted in our resilient business performance throughout the year. The pandemic has also allowed us to refine further our capabilities of the Company accumulated over the years for “Industry Operations + Industrial Investment”, FC2M model, globalization and technology innovation. Fosun has thus evolved and become even stronger. The theme of Fosun’s annual report this year is “Innovation & Win”. “Innovation” means Fosun always attaches great importance to innovation. We recognize that we can create world-class products only by increasing investment in innovation and R&D. It is also because of our investment in technology innovation in various industries over the years, as well as leveraging on Fosun’s diversified and globalized business portfolio, the development model of “Industry Operations + Industrial Investment”, and the “wartime” mode that it has upkept since the battle against the pandemic, that together effectively defended the impact brought by the external environment and brought the Group a resilient performance, thereby creating mutually beneficial and win-win situation to all stakeholders. The year 2021 is a new starting point for Fosun’s transformation. Facing the huge opportunities in the industrial internet era, we will continue to create good products and put the operation of customers (C-end) as our top priority to fully unlock the multiplier growth of good products and customer resources in Fosun’s ecosystem.
  • Biontech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine

    Biontech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine

    BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine January 25, 2021 COMIRNATY® (also known as BNT162b2, Chinese product name: 復必泰TM) is the first COVID-19 vaccine to receive Authorization for Emergency Use in Hong Kong MAINZ, GERMANY, and SHANGHAI, CHINA, January 25, 2021 —BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma” or “Group”; Stock Code: 600196.SH, 02196.HK) today announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC (“Hong Kong”), the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chinese product name: 復必泰TM) based on BioNTech’s proprietary mRNA technology has received authorization for emergency use in Hong Kong. The vaccine will be produced in BioNTech’s manufacturing facilities in Germany and supplied to Hong Kong for administration under the Hong Kong SAR Government’s COVID-19 Vaccination Program. “We are excited and encouraged that COMIRNATY® has been authorized to emergency use in Hong Kong. This is an important milestone in the joint efforts of BioNTech and Fosun Pharma to achieve vaccine accessibility globally. We will continue working closely with BioNTech to complete the ongoing clinical trial and marketing registration in Greater China,” Wu Yifang, Chairman and CEO of Fosun Pharma said. “We will also cooperate closely with HKSAR regarding vaccination deployment plan to ensure that Hong Kong citizens can receive a well-tolerated and effective mRNA COVID-19 vaccine as soon as possible in order to protect the health of millions of households.” On 16 March 2020, BioNTech and Fosun Pharma announced a strategic collaboration to work jointly on the development and commercialization of a COVID-19 vaccine product in Greater China based on BioNTech’s proprietary mRNA technology platform.
  • STOXX Hong Kong All Shares 50 Last Updated: 01.12.2016

    STOXX Hong Kong All Shares 50 Last Updated: 01.12.2016

    STOXX Hong Kong All Shares 50 Last Updated: 01.12.2016 Rank Rank (PREVIOUS ISIN Sedol RIC Int.Key Company Name Country Currency Component FF Mcap (BEUR) (FINAL) ) KYG875721634 BMMV2K8 0700.HK B01CT3 Tencent Holdings Ltd. CN HKD Y 128.4 1 1 HK0000069689 B4TX8S1 1299.HK HK1013 AIA GROUP HK HKD Y 69.3 2 2 CNE1000002H1 B0LMTQ3 0939.HK CN0010 CHINA CONSTRUCTION BANK CORP H CN HKD Y 60.3 3 4 HK0941009539 6073556 0941.HK 607355 China Mobile Ltd. CN HKD Y 57.5 4 3 CNE1000003G1 B1G1QD8 1398.HK CN0021 ICBC H CN HKD Y 37.7 5 5 CNE1000001Z5 B154564 3988.HK CN0032 BANK OF CHINA 'H' CN HKD Y 32.6 6 7 KYG217651051 BW9P816 0001.HK 619027 CK HUTCHISON HOLDINGS HK HKD Y 32.0 7 6 HK0388045442 6267359 0388.HK 626735 Hong Kong Exchanges & Clearing HK HKD Y 28.5 8 8 CNE1000003X6 B01FLR7 2318.HK CN0076 PING AN INSUR GP CO. OF CN 'H' CN HKD Y 26.5 9 9 CNE1000002L3 6718976 2628.HK CN0043 China Life Insurance Co 'H' CN HKD Y 20.4 10 15 HK0016000132 6859927 0016.HK 685992 Sun Hung Kai Properties Ltd. HK HKD Y 19.4 11 10 HK0883013259 B00G0S5 0883.HK 617994 CNOOC Ltd. CN HKD Y 18.9 12 12 HK0002007356 6097017 0002.HK 619091 CLP Holdings Ltd. HK HKD Y 18.3 13 13 KYG2103F1019 BWX52N2 1113.HK HK50CI CK Property Holdings HK HKD Y 17.9 14 11 CNE1000002Q2 6291819 0386.HK CN0098 China Petroleum & Chemical 'H' CN HKD Y 16.8 15 14 HK0688002218 6192150 0688.HK 619215 China Overseas Land & Investme CN HKD Y 14.8 16 16 HK0823032773 B0PB4M7 0823.HK B0PB4M Link Real Estate Investment Tr HK HKD Y 14.6 17 17 CNE1000003W8 6226576 0857.HK CN0065 PetroChina Co Ltd 'H' CN HKD Y 13.5 18 19 HK0003000038 6436557 0003.HK 643655 Hong Kong & China Gas Co.
  • China Reits Property Landlords to Shine 19

    China Reits Property Landlords to Shine 19

    SECTOR BRIEFING number DBS Asian Insights DBS Group59 Research • May 2018 China REITs Property Landlords to Shine 19 DBS Asian Insights SECTOR BRIEFING 59 02 China REITs Property Landlords to Shine Ken HE Equity Analyst DBS (Hong Kong) [email protected] Carol WU Head of Greater China Research DBS (Hong Kong) [email protected] Danielle WANG CFA Equity Analyst DBS (Hong Kong) [email protected] Derek TAN Equity Analyst DBS Group Research [email protected] Jason LAM Equity Analyst DBS (Hong Kong) [email protected] Produced by: Asian Insights Office • DBS Group Research go.dbs.com/research @dbsinsights [email protected] Goh Chien Yen Editor-in-Chief Jean Chua Managing Editor Martin Tacchi Art Director 19 DBS Asian Insights SECTOR BRIEFING 59 03 04 Executive Summary 08 China REITs Are Lagging Edging Towards Onshore REITs Major Obstacles in Fostering 18 an Onshore REIT Regime CMBS/CMBNs Are Growing Faster C-REITs Are Imminent Which Asset Type Will Benefit 28 More? Modern Logistics Properties The Rise of Active Property Asset Management Which Developer Will Benefit From the Establishment of C-REITs? 49 Appendix DBS Asian Insights SECTOR BRIEFING 59 04 Executive Summary No REIT regime yet he real estate investment trust (REIT) has become an important investment vehicle as evidenced by its separation from the financial sector in the Global Industry Classification Standard as a sector on its own. Major Asian countries/regions have joined western countries to kickstart local versions of REITs, leaving China the last Tbig economy that has yet to have such an investment vehicle. Two major technical In our view, removing legislative obstacles (publicly traded funds are not allowed to obstacles hold commercial properties) is the first step that the government needs to take towards establishing a modern REIT regime.
  • China Equity Strategy

    China Equity Strategy

    June 5, 2019 09:40 AM GMT MORGAN STANLEY ASIA LIMITED+ China Equity Strategy | Asia Pacific Jonathan F Garner EQUITY STRATEGIST [email protected] +852 2848-7288 The Rubio "Equitable Act" - Our Laura Wang EQUITY STRATEGIST [email protected] +852 2848-6853 First Thoughts Corey Ng, CFA EQUITY STRATEGIST [email protected] +852 2848-5523 Fran Chen, CFA A new bill sponsored by US Senator Marco Rubio has the EQUITY STRATEGIST potential to cause significant change in the listing domains of [email protected] +852 2848-7135 Chinese firms. After the market close in the US yesterday 4th June the Wall Street Journal published an Op-Ed by US Senator Marco Rubio in which he announced that he intends to sponsor the “Equitable Act” – an acronym for Ensuring Quality Information and Transparency for Abroad-Based Listings on our Exchanges. At this time the text of the bill has not been published and we are seeking additional information about its contents and likelihood of passing. However, our early reaction is that this has the potential to cause significant changes in the domain for listings of Chinese firms going forward with the potential for de- listing of Chinese firms on US exchanges and re-listing elsewhere (most likely Hong Kong). More generally we see this development as part of an increased escalation of tensions between China and the US on multiple fronts which should cap the valuation multiple for China equities, in particular in the offshore index constituents and US-listed parts of the universe. We provide a list of the potentially impacted China / HK names with either primary or secondary listings on Amex, NYSE or Nasdaq.
  • 2020 Interim Results Announcement

    2020 Interim Results Announcement

    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. (incorporated in Hong Kong under the Companies Ordinance with limited liability) (Stock code: 285) 2020 INTERIM RESULTS ANNOUNCEMENT The Board of Directors of the Company (the “Board”) is pleased to announce the unaudited results of the Company and its subsidiaries for the six months period ended 30 June 2020. This announcement, containing the full text of the 2020 Interim Report of the Company, is prepared with reference to the relevant requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited in relation to preliminary announcements of interim results. Printed version of the Company’s 2020 Interim Report will be delivered to the Company’s shareholders and is also available for viewing on the websites of Hong Kong Exchanges and Clearing Limited at http://www.hkex.com.hk and of the Company at http://www.byd-electronics.com. By Order of the Board of BYD Electronic (International) Company Limited WANG Nian-qiang Director Hong Kong, 28 August 2020 As at the date of this announcement, the executive Directors of the Company are Mr. WANG Nian- qiang and Mr. JIANG Xiang-rong; the non-executive Directors are Mr. WANG Chuan-fu and Mr. WANG Bo; and the independent non-executive Directors are Mr.
  • ACAL China Equity Nov17

    ACAL China Equity Nov17

    ARETE CAPITAL ASIA CHINA: VALUE IN SELECTED NAMES CHINA EQUITY – OVERVIEW CHINA IS TAKING ITS PLACE ON THE WORLD STAGE • China is a critical player in the world economy and is the worlds largest economy on a purchasing power parity basis. • Xi’s position has been reinforced for the next 5yrs and possibly beyond. The new leadership will retain existing key policies with a focus on economic reform and an emphasis on foreign policy. ECONOMIC TRANSFORMATION WELL UNDERWAY • ‘Smokestack’ industries (coal, aluminium and steel) and ‘providing for populace’ businesses (consumer staples and healthcare) are no longer so dominant and being overtaken by manufacturers and service companies. • In many cases, these new ‘service’ industries are redefining business models in established sectors • The China government has selected and carefully encouraged special policies/industries to have Chinese operations challenge the established order – internally and externally INVESTMENT OPPORTUNITIES EXIST • Amongst the many transformations taking place in China, there are numerous great investment opportunities. We do not recommend an index, but selected stocks • Some of these stocks have made significant gains over the last 12months, but there is still more to come 2 CONTENT OVERVIEW ECONOMY Economy Issues Diversification 4 5 6 Equities Remninbi VALUATIONS 7 8 SITUATIONS MiddlePORTFOLIO Class ecosystem ADVISORY 9 10 SELECTED STOCKS Preferred 11 Valuations 13 3 CHINA – ECONOMY CHINA’s ECONOMIC GROWTH REMAINS RESILIENT … • IMF forecasts (not a leading indicator)
  • Hang Seng Indexes Announces Index Review Results

    Hang Seng Indexes Announces Index Review Results

    14 August 2020 Hang Seng Indexes Announces Index Review Results Hang Seng Indexes Company Limited (“Hang Seng Indexes”) today announced the results of its review of the Hang Seng Family of Indexes for the quarter ended 30 June 2020. All changes will take effect on 7 September 2020 (Monday). 1. Hang Seng Index The following constituent changes will be made to the Hang Seng Index. The total number of constituents remains unchanged at 50. Inclusion: Code Company 1810 Xiaomi Corporation - W 2269 WuXi Biologics (Cayman) Inc. 9988 Alibaba Group Holding Ltd. - SW Removal: Code Company 83 Sino Land Co. Ltd. 151 Want Want China Holdings Ltd. 1088 China Shenhua Energy Co. Ltd. - H Shares The list of constituents is provided in Appendix 1. The Hang Seng Index Advisory Committee today reviewed the fast expanding innovation and new economy sectors in the Hong Kong capital market and agreed with the proposal from Hang Seng Indexes to conduct a comprehensive study on the composition of the Hang Seng Index. This holistic review will encompass various aspects including, but not limited to, composition and selection of constituents, number of constituents, weightings, and industry and geographical representation, etc. The underlying aim of the study is to ensure the Hang Seng Index continues to serve as the most representative and important benchmark of the Hong Kong stock market. Hang Seng Indexes will report its findings and propose recommendations to the Advisory Committee within six months. The number of constituents of the Hang Seng Index may increase during this period. Hang Seng Indexes Announces Index Review Results /2 2.
  • Real Estate and Construction-210204-EN

    Real Estate and Construction-210204-EN

    Real Estate and Construction Beijing Guangzhou Hong Kong Shanghai Shenzhen 27/F, North Tower 17/F, International Finance 26/F, One Exchange Square 24/F, HKRI Centre Two, 17/F, Tower One, Kerry Plaza Beijing Kerry Centre Place, 8 Huaxia Road, 8 Connaught Place, Central HKRI Taikoo Hui 1 Zhong Xin Si Road 1 Guanghua Road Zhujiang New Town Hong Kong 288 Shi Men Yi Road Futian District Chaoyang District Guangzhou 510623, China Shanghai 200041, China Shenzhen 518048, China Beijing 100020, China Tel: +86 10 5769 5600 Tel: +86 20 3225 3888 Tel: +852 3976 8888 Tel: +86 21 2208 1166 Tel: +86 755 8159 3999 Fax:+86 10 5769 5788 Fax:+86 20 3225 3899 Fax:+852 2110 4285 Fax:+86 21 5298 5599 Fax:+86 755 8159 3900 www.fangdalaw.com Real Estate and Construction 01 Real Estate and Construction Practice Fangda’s Real Estate and Construction Practice Team excels at providing one-stop and full-scale services to leading real estate market players, including real estate developers, real estate private equity sponsors, institutional investors, financial institutions and other corporations and individuals in complicated domestic and cross-border real estate transactions. Our lawyers are frequently appointed as arbitrators in real estate and construction-related disputes. Our strength in this area includes a combination of understanding the traditions of the Chinese market and practice and our abundant experience in serving international clients, complemented by services for non-contentious and contentious cases. We are one of the few firms based in China that can provide integrated real estate and construction related legal services, and present practical advice based on our knowledge and experience in the local market.